Overview
A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.
Indication
Used to control moderate to severe pain.
Associated Conditions
- Severe Pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/01/15 | Phase 3 | Recruiting | |||
2024/12/17 | Phase 4 | Not yet recruiting | Fondazione Andrea Cesalpino Arezzo ONLUS | ||
2024/08/19 | Phase 4 | Completed | Ismail Tekin | ||
2024/07/22 | Phase 4 | Not yet recruiting | |||
2024/03/22 | Phase 2 | Recruiting | Kasr El Aini Hospital | ||
2023/11/01 | Phase 2 | Completed | National University of Malaysia | ||
2023/10/13 | Phase 2 | Not yet recruiting | |||
2023/01/25 | Not Applicable | Completed | |||
2022/08/12 | Not Applicable | Completed | Medipol University | ||
2022/05/23 | Phase 4 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Physicians Total Care, Inc. | 54868-5808 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 50 mg in 1 mL | 12/28/2011 | |
Hospira, Inc. | 0409-1179 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 75 mg in 1 mL | 4/2/2024 | |
Hikma Pharmaceuticals USA Inc. | 0641-6054 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 100 mg in 1 mL | 1/30/2024 | |
Physicians Total Care, Inc. | 54868-3559 | INTRAMUSCULAR | 50 mg in 1 mL | 5/6/2010 | |
Hospira, Inc. | 0409-1362 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 25 mg in 1 mL | 4/2/2024 | |
Hikma Pharmaceuticals USA Inc. | 0054-4595 | ORAL | 50 mg in 1 1 | 4/18/2020 | |
Hikma Pharmaceuticals USA Inc. | 0641-6052 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 25 mg in 1 mL | 1/30/2024 | |
Hikma Pharmaceuticals USA Inc. | 0641-6053 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 50 mg in 1 mL | 1/30/2024 | |
Hospira, Inc. | 0409-1180 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 100 mg in 1 mL | 4/2/2024 | |
Validus Pharmaceuticals LLC | 30698-337 | ORAL | 100 mg in 1 1 | 1/24/2024 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
Pethidine-hameln Solution for Injection 50mg/ml | SIN14662P | INJECTION, SOLUTION | 50mg | 11/14/2014 | |
DBL PETHIDINE HYDROCHLORIDE INJECTION BP 50mg/ml | SIN00753P | INJECTION | 50 mg/ml | 5/4/1988 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
DEMOTHINE SOLUTION FOR INJECTION 100MG/2ML | N/A | N/A | N/A | 1/25/2024 | |
DEMOTHINE SOLUTION FOR INJECTION 50MG/1ML | N/A | N/A | N/A | 1/25/2024 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
DBL PETHIDINE HYDROCHLORIDE 100mg/2mL Injection | 107387 | Medicine | A | 12/15/2004 | |
NOUMED PETHIDINE TABLETS pethidine hydrochloride 50 mg uncoated tablet bottle | 397893 | Medicine | A | 10/17/2022 | |
PETHIDINE JUNO pethidine injection BP 100mg/2mL ampoule | 340377 | Medicine | A | 9/28/2020 | |
DBL PETHIDINE HYDROCHLORIDE 50mg/1mL Injection | 107386 | Medicine | A | 12/15/2004 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
MEPERIDINE HYDROCHLORIDE INJECTION USP | 00725765 | Solution - Subcutaneous
,
Intravenous
,
Intramuscular | 50 MG / ML | 12/31/1987 | |
MEPERIDINE HCL INJECTION 50MG/ML | hospira healthcare ulc | 00497452 | Solution - Intravenous
,
Subcutaneous
,
Intramuscular | 50 MG / ML | 12/31/1981 |
MEPERIDINE HYDROCHLORIDE INJECTION USP | 00725749 | Solution - Intravenous
,
Subcutaneous
,
Intramuscular | 100 MG / ML | 12/31/1988 | |
DEMEROL 100 MG/ML | hospira healthcare ulc | 02242006 | Solution - Intramuscular
,
Subcutaneous | 100 MG / ML | 5/1/2000 |
DEMEROL 50 MG/ML (MULTIPLE DOSE WITH METACRESOL AS PRESERVATIVE) | hospira healthcare ulc | 02242002 | Solution - Subcutaneous
,
Intramuscular | 50 MG / ML | 12/1/2000 |
MEPERIDINE HCL INJECTION 10MG/ML | hospira healthcare ulc | 00497436 | Solution - Intravenous
,
Subcutaneous
,
Intramuscular | 10 MG / ML | 12/31/1981 |
MEPERIDINE HCL INJECTION 75MG/ML | hospira healthcare ulc | 00497460 | Solution - Intramuscular
,
Intravenous
,
Subcutaneous | 75 MG / ML | 12/31/1981 |
MEPERIDINE HYDROCHLORIDE INJECTION USP | ICU Medical Canada Inc | 00640409 | Solution - Intravenous | 10 MG / ML | 12/31/1986 |
DEMEROL 50MG - LIQ IM SC 50MG/ML | sanofi canada, inc. | 02137992 | Liquid - Subcutaneous
,
Intramuscular | 50 MG / ML | 12/31/1944 |
PETHIDINE INJECTION B.P. | hospira healthcare ulc | 02208148 | Solution - Intravenous | 10 MG / ML | 9/24/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.